KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash from Operations: 2017-2025

Historic Cash from Operations for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $219.0 million.

  • Elanco Animal Health's Cash from Operations rose 35.19% to $219.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $629.0 million, marking a year-over-year increase of 20.73%. This contributed to the annual value of $541.0 million for FY2024, which is 99.63% up from last year.
  • Elanco Animal Health's Cash from Operations amounted to $219.0 million in Q3 2025, which was down 7.59% from $237.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Cash from Operations high stood at $312.0 million for Q2 2022, and its period low was -$145.0 million during Q1 2023.
  • For the 3-year period, Elanco Animal Health's Cash from Operations averaged around $114.9 million, with its median value being $162.0 million (2024).
  • Per our database at Business Quant, Elanco Animal Health's Cash from Operations plummeted by 381.82% in 2022 and then skyrocketed by 1,107.69% in 2023.
  • Over the past 5 years, Elanco Animal Health's Cash from Operations (Quarterly) stood at $223.0 million in 2021, then crashed by 94.17% to $13.0 million in 2022, then surged by 1,107.69% to $157.0 million in 2023, then climbed by 12.74% to $177.0 million in 2024, then skyrocketed by 35.19% to $219.0 million in 2025.
  • Its last three reported values are $219.0 million in Q3 2025, $237.0 million for Q2 2025, and -$4.0 million during Q1 2025.